Benzinga | Nov 9, 2021 11:06AM EST

Coherus BioSciences Q3 EPS $(0.34) Misses $(0.22) Estimate, Sales $82.50M Miss $91.31M Estimate

Coherus BioSciences (NASDAQ:CHRS) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.22) by 54.55 percent. This is a 172.34 percent decrease over earnings of $0.47 per share from the same period last year. The company reported quarterly sales of $82.50 million which missed the analyst consensus estimate of $91.31 million by 9.65 percent. This is a 27.34 percent decrease over sales of $113.55 million the same period last year.